Immunologic Factors - Research News and Information

Saturday, January 10, 2009

Bowel loops and eyelid droops.

19 Oct 2008 A patient presented with a small-bowel obstruction associated with signs and symptoms of botulism. Fecal cultures were positive for viable Clostridium botulinum. This case emphasizes the importance of a broad differential diagnosis and doing a ... Read more...

Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis.

14 Oct 2008 Educating dendritic cells (DC) to become tolerogenic DC, which promote regulatory IL-10 immune responses, represents an effective immune evasion strategy for pathogens. Yersinia pestis virulence factor LcrV is reported to induce IL-10 production ... Read more...

Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils.

13 Oct 2008 Peripheral blood neutrophils from periodontitis patients exhibit a hyperreactive and hyperactive phenotype (collectively termed hyperresponsivity) in terms of production of reactive oxygen species (ROS). The molecular basis for this phenomenon, ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Immunologic Factors'

These are the very latest articles for this heading:

• Bowel loops and eyelid droops. 19 Oct 2008
• Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. 14 Oct 2008
• Desensitization during renal transplantation. 14 Oct 2008
• Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils. 13 Oct 2008
• Insights into inflammation and influenza. 7 Oct 2008
• Locoregional treatment of malignant hepatic tumors with biologic response modifiers. 29 Sep 2008
• Advances in biotechnology and novel insights into pathophysiology have contributed to an increased understanding of the pathomechanisms of diseases affecting the peripheral nervous system. 29 Sep 2008
• Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine. 29 Sep 2008
• Spondyloarthritis at the crossroads of imaging, pathology, and structural damage in the era of biologics. 29 Sep 2008
• Tumor necrosis factor inhibitors and infection complications. 29 Sep 2008
• Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazin-3-one. 29 Sep 2008
• [Treatment for multiple myeloma: current status and future strategy in Japan] 29 Sep 2008
• Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. 29 Sep 2008
• Immune activation early in pregnancy: trouble down the road? 29 Sep 2008
• Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. 29 Sep 2008
• Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab. 25 Sep 2008
• Soluble CD4 broadens neutralization of V3-directed monoclonal antibodies and guinea pig vaccine sera against HIV-1 subtype B and C reference viruses. 16 Sep 2008
• Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. 13 Sep 2008
• Translational Research Working Group developmental pathway for immune response modifiers. 13 Sep 2008
• Monoclonal antibody pharmacokinetics and pharmacodynamics. 8 Sep 2008

See a longer list of these articles.

Technical information about 'Immunologic Factors'

Definition: Biologically active substances whose activities affect or play a role in the functioning of the immune system.

Registry Number: 0

Descriptor UI: D007155

Alternative terms: Immunologic Factors; Immune Factors; Factors, Immune; Immunological Factors; Factors, Immunological; Factors, Immunologic; Immunomodulators; Biological Response Modifiers; Modifiers, Biological Response; Response Modifiers, Biological; Biomodulators;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.696.477;

History Note: 1998; for IMMUNOMODULATORS use ADJUVANTS, IMMUNOLOGIC 1980-2004